- Home
- NLSP vs ALBT Comparison
NLSP vs ALBT Comparison
Compare NLSP & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- ALBT
- Stock Information
- Founded
- NLSP 2015
- ALBT 2014
- Country
- NLSP Switzerland
- ALBT United States
- Employees
- NLSP N/A
- ALBT N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NLSP Health Care
- ALBT Health Care
- Exchange
- NLSP Nasdaq
- ALBT Nasdaq
- Market Cap
- NLSP 243.8M
- ALBT 2.9M
- IPO Year
- NLSP 2021
- ALBT N/A
- Fundamental
- Price
- NLSP $4.96
- ALBT $0.20
- Analyst Decision
- NLSP
- ALBT
- Analyst Count
- NLSP 0
- ALBT 0
- Target Price
- NLSP N/A
- ALBT N/A
- AVG Volume (30 Days)
- NLSP 34.6K
- ALBT 639.6K
- Earning Date
- NLSP 11-01-2024
- ALBT 11-12-2024
- Dividend Yield
- NLSP N/A
- ALBT N/A
- EPS Growth
- NLSP N/A
- ALBT N/A
- EPS
- NLSP N/A
- ALBT N/A
- Revenue
- NLSP N/A
- ALBT N/A
- Revenue This Year
- NLSP N/A
- ALBT N/A
- Revenue Next Year
- NLSP N/A
- ALBT N/A
- P/E Ratio
- NLSP N/A
- ALBT N/A
- Revenue Growth
- NLSP N/A
- ALBT N/A
- 52 Week Low
- NLSP $4.08
- ALBT $0.16
- 52 Week High
- NLSP $29.68
- ALBT $1.44
- Technical
- Relative Strength Index (RSI)
- NLSP 46.37
- ALBT 42.61
- Support Level
- NLSP $4.52
- ALBT $0.16
- Resistance Level
- NLSP $5.64
- ALBT $0.30
- Average True Range (ATR)
- NLSP 0.48
- ALBT 0.03
- MACD
- NLSP 0.07
- ALBT 0.00
- Stochastic Oscillator
- NLSP 55.44
- ALBT 26.09
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.